Global Information
회사소개 | 문의 | 비교리스트

세계의 혈액검사 시장 조사 및 예측

Global Blood screening Market Research and Forecast 2018-2023

리서치사 Orion Market Research Pvt Ltd
발행일 2018년 07월 상품 코드 670563
페이지 정보 영문
가격
US $ 3,600 ₩ 4,254,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,672,000 Printable PDF (Enterprise License)


세계의 혈액검사 시장 조사 및 예측 Global Blood screening Market Research and Forecast 2018-2023
발행일 : 2018년 07월 페이지 정보 : 영문

세계의 혈액검사(Blood screening) 시장을 조사했으며, 시장 개요, 검사 기술·최종사용자·제품·지역별 시장 규모 추이와 예측, 시장 동향, 성장 촉진요인 및 저해요인, 시장 기회, 규제 환경, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 보고서 개요

  • 조사 방법
  • 시장 분석
    • 부문별
    • 지역별
    • 이해관계자별

제2장 시장 개요와 인사이트

  • 시장 정의
  • 분석 인사이트 및 현재 시장 동향
    • 주요 조사결과
    • 제안
    • 결론
  • 규제 환경
    • 미국
    • EU
    • 중국
    • 인도

제3장 시장 영향요인

  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회

제4장 시장 세분화

  • 세계의 혈액검사 시장 : 검사 기술별
    • 핵산증폭검사(NAT)
    • 웨스턴 블로팅(WB)
    • 효소면역측정법(ELISA)
    • PCR-RNA
  • 세계의 혈액검사 시장 : 최종사용자별
    • 혈액은행
    • 병원
    • 연구실
  • 세계의 혈액검사 시장 : 제품별
    • 검사기구
    • 시약

제5장 경쟁 구도

  • 주요 전략
  • 주요 기업 분석

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타
  • 아시아태평양
    • 인도
    • 중국
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • ABBOTT LABORATORIES
  • ACRIS ANTIBODIES GMBH
  • BECTON DICKINSON AND COMPANY
  • BIOAIM SCIENTIFIC INC
  • BIOMERIEUX, INC
  • BIO-RAD LABORATORIES, INC
  • BIOVISION INC
  • BOSTER BIOLOGICAL TECHNOLOGY
  • CUSABIO TECHNOLOGY LLC
  • DANAHER CORPORATION
  • DEMEDITEC DIAGNOSTICS GMBH
  • F. HOFFMANN-LA ROCHE LTD.
  • GRIFOLS
  • IBL-AMERICA
  • INNOVATIVE RESEARCH
  • KOMABIOTECH
  • ORTHO-CLINICAL DIAGNOSTICS, INC.
  • RAYBIOTECH, INC.
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC

도표

LSH 18.08.10

List of Tables

  • TABLE # 1 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY,2017-2023($ MILLION)
  • TABLE # 2 GLOBAL NUCLEIC ACID AMPLIFICATION TEST MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 3 GLOBAL WESTERN BLOTTING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 4 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 5 GLOBAL PCR-RNA MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 6 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS ,2017-2023($ MILLION)
  • TABLE # 7 GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 8 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 9 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 10 GLOBAL BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS ,2017-2023($ MILLION)
  • TABLE # 11 GLOBAL TESTING INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 12 GLOBAL REAGENTS MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
  • TABLE # 13 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 14 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
  • TABLE # 15 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
  • TABLE # 16 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 17 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
  • TABLE # 18 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
  • TABLE # 19 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY SCREENING TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 20 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY END-USERS, 2017-2023($ MILLION)
  • TABLE # 21 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2017-2023($ MILLION)
  • TABLE # 22 REST OF THE WORLD (ROW) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL BLOOD SCREENING MARKET SHARE, BY SCREENING TECHNOLOGY, 2017 VS 2023($ MILLION)
  • FIGURE # 2 GLOBAL BLOOD SCREENING MARKET SHARE, BY END USERS, 2017 VS 2023($ MILLION)
  • FIGURE # 3 GLOBAL BLOOD SCREENING MARKET SHARE, BY PRODUCTS, 2017 VS 2023($ MILLION)
  • FIGURE # 4 NORTH AMERICA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 5 UNITED STATES BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 7 EUROPE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 8 UK BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 9 GERMANY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 10 SPAIN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 11 FRANCE BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 12 ITALY BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 13 REST OF EUROPE (ROE) BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 14 ASIA PACIFIC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 15 INDIA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 16 CHINA BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 17 JAPAN BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 18 ROAPAC BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 19 REST OF THE WORLD BLOOD SCREENING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)

Blood screening is the process of testing of blood units to ensure the safety of collected blood. The donated blood is required to be screened in order to check the presence of various biomarkers, infections in the blood units. The screened blood when pass the screening tests is preserved and used by blood banks, hospitals and laboratories. The rising prevalence of infectious diseases and demand for safe blood units is major driver for the growth of market. The rapid adoption of latest screening technologies such as nucleic acid amplification test and awareness about blood donations are also some of the factors behind the growth of market. The complex regulations and high initial set up cost for blood bank and screening test is the major restraining factor, however the advancement in latest screening processes such as microbiology screening and increase in government expenditure in healthcare will create more growth opportunity.

The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. The North American region dominates the global blood screening market due to the rising prevalence of infectious diseases and the advanced healthcare technologies. The extended support of government and rapid adoption of advanced screening test such as nucleic acid amplification test is also propelling the market in the region. The countries such as India and China in Asia pacific region is expected to grow tremendously in the forecasted period due to rapid development of healthcare infrastructure and awareness about blood donations.

The company engaged in Blood screening market provides various types screening tests such as nucleic acid amplification test, ELISA, PCR-RNA and western blotting, the organization also manufactures reagents and testing instruments. The Key Players in the Blood screening market are Abbott Laboratories, Acris Antibodies GmbH, Becton Dickinson and Company, BioAim Scientific Inc, BioMerieux, Inc, Bio-Rad Laboratories, Inc, BioVision Inc, Boster Biological Technology, Cusabio Technology LLC, Danaher Corporation, Demeditec Diagnostics GmbH, F. Hoffmann-La Roche Ltd., Grifols, IBL-America and so on.

Research Methodology

The market study of Global Blood screening market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases (org, gov and other such websites)
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.

The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation:

  • Global Blood screening Market is segmented on the basis of various regions and below mentioned segments:
  • Global Blood screening Market Research and Analysis, By Screening technology
  • Global Blood screening Market Research and Analysis, By End users
  • Global Blood screening Market Research and Analysis, By Product

The Report covers:

  • Comprehensive research methodology of Global Blood screening market
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Blood screening
  • Insights about market determinants which are stimulating the Global Blood screening
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATION
      • 2.3.1.1. UNITED STATES
      • 2.3.1.2. EUROPEAN UNION
      • 2.3.1.3. CHINA
      • 2.3.1.4. INDIA

3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. SAFETY CONCERN REGARDING BLOOD CONTAMINATION
    • 3.1.2. INCREASING PREVALENCE OF INFECTIOUS DISEASES
    • 3.1.3. ADOPTION OF NUCLEIC ACID AMPLIFICATION TEST
    • 3.1.4. RISING AWARENESS ABOUT BLOOD DONATIONS
    • 3.1.5. TECHNOLOGICAL ADVANCEMENT IN SCREENING TECHNOLOGY SUCH AS MICROBIOLOGY SCREENING.
  • 3.2. RESTRAINT
    • 3.2.1. COMPLEXITY IN REGULATIONS
    • 3.2.2. HIGH INITIAL INVESTMENT FOR BLOOD BANKS
  • 3.3. OPPORTUNITY
    • 3.3.1. INCREASING GOVERNMENT INITIATIVES AND INVESTMENT
    • 3.3.2. MICROFLUID TECHNOLOGIES ARE CHANGING THE BLOOD SCREENING INDUSTRY

4. MARKET SEGMENTATION

  • 4.1. GLOBAL BLOOD SCREENING MARKET, BY SCREENING TECHNOLOGY
    • 4.1.1. NUCLEIC ACID AMPLIFICATION TEST
    • 4.1.2. WESTERN BLOTTING
    • 4.1.3. ENZYME-LINKED IMMUNOSORBENT ASSAY
    • 4.1.4. PCR-RNA
  • 4.2. GLOBAL BLOOD SCREENING MARKET, BY END-USERS
    • 4.2.1. BLOOD BANKS
    • 4.2.2. HOSPITALS
    • 4.2.3. LABORATORIES
  • 4.3. GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS
    • 4.3.1. TESTING INSTRUMENTS
    • 4.3.2. REAGENTS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
  • 5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. UK
    • 6.2.2. GERMANY
    • 6.2.3. SPAIN
    • 6.2.4. FRANCE
    • 6.2.5. ITALY
    • 6.2.6. REST OF EUROPE
  • 6.3. APAC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
    • 6.3.4. REST OF APAC
  • 6.4. REST OF THE WORLD

7. COMPANY PROFILES

  • 7.1. ABBOTT LABORATORIES
  • 7.2. ACRIS ANTIBODIES GMBH
  • 7.3. BECTON DICKINSON AND COMPANY
  • 7.4. BIOAIM SCIENTIFIC INC
  • 7.5. BIOMERIEUX, INC
  • 7.6. BIO-RAD LABORATORIES, INC
  • 7.7. BIOVISION INC
  • 7.8. BOSTER BIOLOGICAL TECHNOLOGY
  • 7.9. CUSABIO TECHNOLOGY LLC
  • 7.10. DANAHER CORPORATION
  • 7.11. DEMEDITEC DIAGNOSTICS GMBH
  • 7.12. F. HOFFMANN-LA ROCHE LTD.
  • 7.13. GRIFOLS
  • 7.14. IBL-AMERICA
  • 7.15. INNOVATIVE RESEARCH
  • 7.16. KOMABIOTECH
  • 7.17. ORTHO-CLINICAL DIAGNOSTICS, INC.
  • 7.18. RAYBIOTECH, INC.
  • 7.19. SIEMENS AG
  • 7.20. THERMO FISHER SCIENTIFIC
Back to Top
전화 문의
F A Q